Cidara Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Cidara Therapeutics, Inc. (CDTX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents189.8335.7832.7359.6835.9160.2774.56
Cash & Short-Term Investments189.8335.7832.7359.6835.9160.2774.56
Accounts Receivable1.6914.085.835.3611.180.012.57
Inventory0.006.100.000.000.000.000.00
Other Current Assets12.871.716.5324.0023.3422.602.57
Total Current Assets210.7460.8645.0971.7057.1965.8177.13
Non-Current Assets
Property, Plant & Equipment (Net)3.965.131.322.541.211.630.71
Other Non-Current Assets0.101.051.071.082.021.101.27
Total Non-Current Assets4.066.182.393.633.232.731.98
Total Assets214.8067.0347.4975.3360.4268.9879.11
Current Liabilities
Accounts Payable3.613.771.4511.5012.539.616.73
Short-Term Debt0.000.000.002.597.020.000.00
Current Portion of Long-Term Debt0.000.000.002.597.020.000.00
Accrued Liabilities44.3037.257.6710.2012.170.000.00
Deferred Revenue0.000.4314.6113.9213.870.000.00
Other Current Liabilities4.9124.6725.454.8618.089.800.41
Total Current Liabilities49.5567.4241.4034.0238.5630.2019.89
Non-Current Liabilities
Long-Term Debt1.933.580.001.320.000.940.00
Other Non-Current Liabilities0.004.2514.6113.9213.870.000.08
Total Non-Current Liabilities1.937.8220.5333.6611.150.940.08
Total Liabilities51.4975.2461.9353.7549.7131.1419.97
Stockholders' Equity
Common Stock0.000.000.010.010.000.000.00
Retained Earnings-611.26-441.43-418.50-377.17-334.70-259.83-218.74
Additional Paid-in Capital774.57433.22404.06398.73345.41297.66277.87
Shares Outstanding10.954.533.623.390.000.000.00
Total Stockholders' Equity163.31-8.21-14.4421.5710.7237.8459.14
Total Liabilities & Equity214.8067.0347.4975.3360.4268.9879.11